Ebola

News Ebola

• Biodefense: Anthrax and Smallpox at the Research Forefront

  As the potential threat of biological terrorist attacks continues to command the attention of governments around the globe, anthrax and smallpox remain amongst the most researched diseases in the biodefense industry, states a new report by GBI Research.The company’s latest study shows that anthrax v more

• Bavarian Nordic Receives NIH Grant to Investigate the Potential of an MVA-BN based Vaccine against Ebola and Marburg Viruses

  Bavarian Nordic A/S announced that the company has received funding from the U.S. National Institutes of Health (NIH) to advance its early research in filoviruses (Ebola and Marburg virus). As previously announced, the company is investigating the potential use of its core vaccine technology, MVA-B more

• Novel 'antisense' therapies protect primates from lethal Ebola and Marburg viruses

  New studies show that treatments targeting specific viral genes protected monkeys infected with deadly Ebola or Marburg viruses. Furthermore, the animals were protected even when therapeutics were administered one hour after exposure — suggesting the approach holds promise for treating accidental in more

White papers Ebola

• Characterizing Environments: Recent Discoveries Enabled by Metagenomic Analysis with the Genome Sequencer FLX System

  Metagenomics is the study of genomic content in a complex mixture of microorganisms. The two primary goals of this approach are to characterize the organisms present in a sample and identify what roles each organism has within a specific environment. Metagenomics samples are found nearly everywhere, including several microenvironments within the human body, soil samples, extreme environments such as deep mines, and the various layers within the ocean. Until recently, technical and economic constraints limited the depth of analysis necessary to obtain a representative picture of microbial and viral communities, their metabolic profiles, and their adaptation dynamics. Advancements in sequencing technologies, including the introduction of massively parallel pyrosequencing with the Genome Sequencer FLX System, have enabled a tremendous groundswell of research in the field of metagenomics. Dramatic improvements in throughput and the elimination of biased cloning steps have extended the field far beyond tradition more

Publications Ebola

• TIM-family Proteins Promote Infection of Multiple Enveloped Viruses through Virion-associated Phosphatidylserine

  by Stephanie Jemielity, Jinyize J. Wang, Ying Kai Chan, Asim A. Ahmed, Wenhui Li, Sheena Monahan, Xia Bu, Michael Farzan, Gordon J. Freeman, Dale T. Umetsu, Rosemarie H. DeKruyff, Hyeryun Choe Human T-cell Immunoglobulin and Mucin-domain containing proteins (TIM1, 3, and 4) specifically b more

• A Cutting‐Edge View on the Current State of Antiviral Drug Development

  Abstract Prominent in the current stage of antiviral drug development are: (i) for human immunodeficiency virus (HIV), the use of fixed‐dose combinations (FDCs), the most recent example being StribildTM; (ii) for hepatitis C virus (HCV), the pleiade of direct‐acting antivirals (DAAs) that should more

• An Upstream Open Reading Frame Modulates Ebola Virus Polymerase Translation and Virus Replication

  by Reed S. Shabman, Thomas Hoenen, Allison Groseth, Omar Jabado, Jennifer M. Binning, Gaya K. Amarasinghe, Heinz Feldmann, Christopher F. Basler Ebolaviruses, highly lethal zoonotic pathogens, possess longer genomes than most other non-segmented negative-strand RNA viruses due in part to more

Market studies Ebola

• Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans

  GBI Research, the leading business intelligence provider has released its latest research report, “Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans”. The report focuses on the key insights into the biodefense industry. The report is bui more

Websites Ebola